RENAL CELL CANCER

This study is testing a new oral medication called Alintegimod, given alongside the immunotherapy drugs ipilimumab and nivolumab. It aims to see if this combination is safe and can help control advanced cancers that have spread or returned after other treatments. The study will e…

This study is looking at how well older adults (70+) with advanced kidney cancer tolerate and respond to a standard two-drug treatment (cabozantinib and nivolumab). Researchers will closely monitor 50 patients' treatment patterns, side effects, and quality of life over time. The …

This study is observing how well the drug vorolanib works and how safe it is for patients with advanced kidney cancer that has spread or cannot be removed by surgery. It involves 39 adults who are receiving vorolanib as their second treatment option. Researchers will track how lo…

This early-stage study is testing a new cancer vaccine called Modi-1. The goal is to see if it is safe and can help the body's immune system fight advanced forms of breast, head and neck, ovarian, and kidney cancer. Researchers will give the vaccine alone or combined with other a…

This study is testing a new type of personalized cancer treatment called CAR-T cell therapy. Doctors take a patient's own immune cells, genetically modify them in a lab to better recognize and attack cancer cells that have a specific marker called CD70, and then infuse them back …

This study is testing whether advanced ultrasound imaging can predict how well a patient's kidneys will work after surgery to remove kidney cancer. Researchers will use special contrast-enhanced ultrasound scans before and after surgery on about 285 patients to see if the images …